Clinical Trial Update: The Efficacy and Tolerability of Coltect as Add-on in Patients With Active Ulcerative Colitis - an Open Label [NA]

View source ↗

Summary

Open-label trial assessing the efficacy and tolerability of Coltect as add-on therapy in patients with active ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Coltect

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Ulcerative Colitis | NA | Status: UNKNOWN